miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Abella, Vanessa ^a   Valladares, Manuel ^a,b   Rodriguez, Teresa ^a   Haz, Mar ^a   Blanco, Moisés ^a   Tarrío, Nuria ^c   Iglesias, Pilar ^b   Aparicio, Luís A ^a,b   Figueroa, Angélica ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b CHUAC   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HAKAI PROTEIN; MICRORNA; MICRORNA 203; PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UVOMORULIN;

3' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MOLECULAR MECHANICS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; TUMOR GROWTH; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MICRORNAS; UBIQUITIN-PROTEIN LIGASES;

EID: 84871427273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052568     Document Type: Article

References (48)

1. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Birchmeier W, Behrens J, (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26.
3. Christofori G, Semb H, (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76.
4. van Roy F, Berx G, (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788.
5. Berx G, van Roy (2009) Involvement of members of the cadherin superfamily in cancer.: Cold Spring Harb Perspect Biol. 1-27.
6. Aparicio LA, Valladares M, Blanco M, Alonso G, Figueroa A (2012) Biological influence of Hakai in cancer: a 10-year review. Cancer Metastasis Rev.
7. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, et al. (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4: 222-231.
8. Palacios F, Tushir J, Fujita Y, D'Souza-Schorey C, (2005) Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 25: 389-402.
9. Hartsock A, Nelson WJ, (2012) Competitive Regulation of E-Cadherin JuxtaMembrane Domain Degradation by p120-Catenin Binding and Hakai-Mediated Ubiquitination. PLoS One 7: e37476.
10. Mukherjee M, Chow SY, Yusoff P, Seetharaman J, Ng C, et al. (2012) Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin. EMBO J.
11. Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Aparicio LA, Figueroa A, (2011) Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer 11: 474.
12. Gong E, Park E, Lee K (2010) Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells. Cancer Sci.
13. Kaido M, Wada H, Shindo M, Hayashi S, (2009) Essential requirement for RING finger E3 ubiquitin ligase Hakai in early embryonic development of Drosophila. Genes Cells 14: 1067-1077.
14. Figueroa A, Kotani H, Toda Y, Mazan-Mamczarz K, Mueller E, et al. (2009) Novel roles of hakai in cell proliferation and oncogenesis. Mol Biol Cell 20: 3533-3542.
15. Figueroa A, Fujita Y, Gorospe M, (2009) Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle 8: 3648-3651.
16. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
17. Meltzer PS, (2005) Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
18. Deng S, Calin GA, Croce CM, Coukos G, Zhang L, (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7: 2643-2646.
19. Croce CM, (2008) Oncogenes and cancer. N Engl J Med 358: 502-511.
20. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
21. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T, et al. (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
22. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
23. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
24. Eulalio A, Huntzinger E, Izaurralde E, (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14.
25. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG, (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37: D155-158.
26. Rodríguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, Blanco M, Aparicio G, et al. (2011) A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics.
27. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
28. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
29. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
30. Yang JY, Zong CS, Xia W, Wei Y, Ali-Seyed M, et al. (2006) MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol 26: 7269-7282.
31. Saini S, Arora S, Majid S, Shahryari V, Chen Y, et al. (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 4: 1698-1709.
32. Li J, Chen Y, Zhao J, Kong F, Zhang Y, (2011) miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett 304: 52-59.
33. Bo J, Yang G, Huo K, Jiang H, Zhang L, et al. (2011) microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278: 786-792.
34. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, et al. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776.
35. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, et al. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506.
36. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, et al. (2011) Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res 17: 5287-5298.
37. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M, (2008) miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci U S A 105: 20297-20302.
38. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
39. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG, (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28: 771-776.
40. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-229.
41. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, et al. (2009) MicroRNA target prediction by expression analysis of host genes. Genome Res 19: 481-490.
42. Yi R, Poy MN, Stoffel M, Fuchs E, (2008) A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452: 225-229.
43. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, et al. (2008) miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 15: 1187-1195.
44. Altieri DC, (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70.
45. Viticchiè G, Lena AM, Latina A, Formosa A, Gregersen LH, et al. (2011) MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10: 1121-1131.
46. Cheng AM, Byrom MW, Shelton J, Ford LP, (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
47. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, et al. (2001) Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20: 77-87.
48. Johnsen SA, Güngör C, Prenzel T, Riethdorf S, Riethdorf L, et al. (2009) Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Res 69: 128-136.